The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies

[1]  T. Seidler,et al.  Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fraction , 2023, European journal of heart failure.

[2]  G. Hasenfuss,et al.  Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial , 2022, EBioMedicine.

[3]  G. Hindricks,et al.  Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. , 2022, The Lancet. Digital health.

[4]  Lennart M. Reinke,et al.  The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics , 2022, European Journal of Epidemiology.

[5]  R. Wachter,et al.  RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress Trial. , 2022, JACC. Cardiovascular imaging.

[6]  M. Mack,et al.  Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. , 2021, The New England journal of medicine.

[7]  I. König,et al.  Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. , 2021, The New England journal of medicine.

[8]  J. Healey,et al.  Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. , 2021, JAMA cardiology.

[9]  R. Wachter,et al.  Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial. , 2020, Circulation.

[10]  Henriette Rau,et al.  The generic Informed Consent Service gICS®: implementation and benefits of a modular consent software tool to master the challenge of electronic consent management in research , 2020, Journal of Translational Medicine.

[11]  I. König,et al.  Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA‐ADHF‐DZHK10 trial , 2020, ESC heart failure.

[12]  P. Ponikowski,et al.  Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy , 2019, ESC heart failure.

[13]  K. Häusler,et al.  Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern , 2019, Herz.

[14]  T. Friede,et al.  Exercise training in patients with a left ventricular assist device (Ex‐VAD): rationale and design of a multicentre, prospective, assessor‐blinded, randomized, controlled trial , 2019, European journal of heart failure.

[15]  S. Blankenberg,et al.  The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients. , 2019, European heart journal.

[16]  K. Häusler,et al.  Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern , 2018, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[17]  Björn Bergh,et al.  MAGIC: once upon a time in consent management—a FHIR® tale , 2018, Journal of Translational Medicine.

[18]  U. Landmesser,et al.  Der katheterbasierte Vorhofohrverschluss – aktuelle Daten und künftige Entwicklungen , 2018, Der Internist.

[19]  C. Skurk,et al.  Aktuelle und zukünftige randomisierte Studien zum Vorhofohr-Okkluder , 2017, Herzschrittmachertherapie + Elektrophysiologie.

[20]  U. Landmesser,et al.  [Recent and upcoming randomized trials for left atrial appendage occlusion : Need for a definite assessment of the situation]. , 2017, Herzschrittmachertherapie & Elektrophysiologie.

[21]  S. Kääb,et al.  Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction: Design and rationale of the SMART-MI trial. , 2017, American heart journal.

[22]  Hugo A. Katus,et al.  Data privacy management and data quality monitoring in the German Centre for Cardiovascular Research's multicentre TranslatiOnal Registry for CardiomyopatHies (DZHK‐TORCH) , 2017, ESC heart failure.

[23]  A. Bauer.  Identifying high-risk post-infarction patients by autonomic testing - Below the tip of the iceberg. , 2017, International journal of cardiology.

[24]  W. Hoffmann,et al.  TranslatiOnal Registry for CardiomyopatHies (TORCH) – rationale and first results , 2017, ESC heart failure.

[25]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[26]  G. Schmidt,et al.  Periodic Repolarisation Dynamics: A Natural Probe of the Ventricular Response to Sympathetic Activation. , 2015, Arrhythmia & electrophysiology review.

[27]  T. Bahls,et al.  MOSAIC – A Modular Approach to Data Management in Epidemiological Studies , 2015, Methods of Information in Medicine.

[28]  T. Bahls,et al.  A workflow-driven approach to integrate generic software modules in a Trusted Third Party , 2015, Journal of Translational Medicine.

[29]  P. Ponikowski,et al.  The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study , 2015, European journal of heart failure.

[30]  Thomas Ganslandt,et al.  Leitfaden zum Datenschutz in medizinischen Forschungsprojekten: Generische Lösungen der TMF 2.0 , 2014 .

[31]  German National Cohort Consortium,et al.  The German National Cohort: aims, study design and organization , 2014, European Journal of Epidemiology.

[32]  Monya Baker,et al.  Biorepositories: Building better biobanks , 2012, Nature.

[33]  O. Raffel,et al.  Left atrial appendage closure for non-valvular atrial fibrillation. , 2012, Heart, Lung and Circulation.

[34]  A. Perren,et al.  Better provenance for biobank samples , 2011, Nature.

[35]  U. Landmesser,et al.  [Catheter-based atrial appendage closure-current data and future developments]. , 2018, Der Internist.